Biochemical, Biomarker, and Behavioral Characterization of the GrnR493X Mouse Model of Frontotemporal Dementia
- PMID: 38696065
- PMCID: PMC11496013
- DOI: 10.1007/s12035-024-04190-9
Biochemical, Biomarker, and Behavioral Characterization of the GrnR493X Mouse Model of Frontotemporal Dementia
Abstract
Heterozygous loss-of-function mutations in the progranulin gene (GRN) are a major cause of frontotemporal dementia due to progranulin haploinsufficiency; complete deficiency of progranulin causes neuronal ceroid lipofuscinosis. Several progranulin-deficient mouse models have been generated, including both knockout mice and knockin mice harboring a common patient mutation (R493X). However, the GrnR493X mouse model has not been characterized completely. Additionally, while homozygous GrnR493X and Grn knockout mice have been extensively studied, data from heterozygous mice is still limited. Here, we performed more in-depth characterization of heterozygous and homozygous GrnR493X knockin mice, which includes biochemical assessments, behavioral studies, and analysis of fluid biomarkers. In the brains of homozygous GrnR493X mice, we found increased phosphorylated TDP-43 along with increased expression of lysosomal genes, markers of microgliosis and astrogliosis, pro-inflammatory cytokines, and complement factors. Heterozygous GrnR493X mice did not have increased TDP-43 phosphorylation but did exhibit limited increases in lysosomal and inflammatory gene expression. Behavioral studies found social and emotional deficits in GrnR493X mice that mirror those observed in Grn knockout mouse models, as well as impairment in memory and executive function. Overall, the GrnR493X knockin mouse model closely phenocopies Grn knockout models. Lastly, in contrast to homozygous knockin mice, heterozygous GrnR493X mice do not have elevated levels of fluid biomarkers previously identified in humans, including neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in both plasma and CSF. These results may help to inform pre-clinical studies that use this Grn knockin mouse model and other Grn knockout models.
Keywords: Biomarkers; Frontotemporal dementia; Mouse model; Neuronal ceroid lipofuscinosis; Progranulin.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Update of
-
Biochemical, biomarker, and behavioral characterization of the GrnR493X mouse model of frontotemporal dementia.bioRxiv [Preprint]. 2024 Feb 2:2023.05.27.542495. doi: 10.1101/2023.05.27.542495. bioRxiv. 2024. Update in: Mol Neurobiol. 2024 Nov;61(11):9708-9722. doi: 10.1007/s12035-024-04190-9 PMID: 37398305 Free PMC article. Updated. Preprint.
Similar articles
-
Biochemical, biomarker, and behavioral characterization of the GrnR493X mouse model of frontotemporal dementia.bioRxiv [Preprint]. 2024 Feb 2:2023.05.27.542495. doi: 10.1101/2023.05.27.542495. bioRxiv. 2024. Update in: Mol Neurobiol. 2024 Nov;61(11):9708-9722. doi: 10.1007/s12035-024-04190-9 PMID: 37398305 Free PMC article. Updated. Preprint.
-
Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice.Acta Neuropathol Commun. 2021 Apr 1;9(1):57. doi: 10.1186/s40478-021-01158-x. Acta Neuropathol Commun. 2021. PMID: 33795008 Free PMC article.
-
Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis.J Neurosci. 2018 Feb 28;38(9):2341-2358. doi: 10.1523/JNEUROSCI.3081-17.2018. Epub 2018 Jan 29. J Neurosci. 2018. PMID: 29378861 Free PMC article.
-
New insights and therapeutic opportunities for progranulin-deficient frontotemporal dementia.Curr Opin Neurobiol. 2022 Feb;72:131-139. doi: 10.1016/j.conb.2021.10.001. Epub 2021 Nov 23. Curr Opin Neurobiol. 2022. PMID: 34826653 Review.
-
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations.Neurotherapeutics. 2023 Jan;20(1):140-153. doi: 10.1007/s13311-023-01348-6. Epub 2023 Feb 13. Neurotherapeutics. 2023. PMID: 36781744 Free PMC article. Review.
Cited by
-
Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease.J Neuroinflammation. 2023 Nov 30;20(1):286. doi: 10.1186/s12974-023-02965-w. J Neuroinflammation. 2023. PMID: 38037070 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous